|
Improve Drug Discovery Decision |
InforSense and Tripos Announce Alliance to
Improve Drug Discovery Decision-Making
Tripos and InforSense partner and work towards
technology integration
|
| ST. LOUIS, MO,
USA, LONDON, UK, & CAMBRIDGE, MA, USA — December 12, 2005 — Tripos, Inc. (Nasdaq:TRPS)
and InforSense today announced an alliance to integrate Tripos’ discovery
informatics portfolio with the award-winning InforSense KDE workflow-based
integrative analytics platform. Through the alliance, Tripos joins
InforSense’s Open Workflow Partner Network (OWPN) and InforSense joins
Tripos’ Alliance Program as a Software Partner. The two companies will also
integrate Tripos’ Auspyx, SYBYL and UNITY technologies with both InforSense
KDE and its ‘in Oracle’ enterprise analytics system, InforSense IOE. This
integration enables customers such as Bayer Healthcare who are using
technology from both companies, to access and integrate Tripos’ discovery
informatics technologies within InforSense KDE, thus streamlining complex
discovery processes to deliver more efficient decision-making and improved
productivity. |
|
Last Updated ( Friday, 16 December 2005 )
|
|
Read more...
|
Although the human genome was sequenced more than five years ago, it can
provide scientists with comparatively few clues to the origins and treatment
of disease. 